Found 24 matching trials
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B) PHASE1 Patients enrolled on this study will have received a stem cell transplant. ...
Show More Location
Texas Childrens Hospital
Learn More & Join Trial
Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT PHASE1 Subjects are having a bone marrow or SCT for either a type of cancer of the...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial
A Phase 2 Study Evaluating JCPyV-specific T Cell Therapy for PML PHASE2 This is a randomized, double-blinded, Phase 2 trial in patients with PML du...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer PHASE1 This study study aims to elucidate the immune responses to a shared antigen...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies PHASE1 The purpose of this study is to test the safety of giving the patient speci...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant PHASE2 This is a Phase 3 study to evaluate posoleucel (ALVR105, Viralym-M); an all...
Show More Location
University of Alabama at Birmingham Children's of Alabama
Learn More & Join Trial
Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C) PHASE1 Patients enrolled on this study will have received a stem cell transplant. ...
Show More Location
Texas Childrens Hospital
Learn More & Join Trial
Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus NA Drug resistance may develop in HIV infected patients who take anti-HIV drug...
Show More Location
San Francisco General Hospital
Learn More & Join Trial
Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC PHASE2 This is an open-label and multi-center Phase 2 study to evaluate the safety...
Show More Location
Multiple Locations
Learn More & Join Trial
A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies PHASE1 The present study is a multi-center, single-arm, open, phase I/IIa clinical...
Show More Location
Samsung Medical Center
Learn More & Join Trial